Longevity biotech companies gero and foxo technologies™ to embark on joint initiative on artificial intelligence and epigenetic data to discover signatures of human health trajectories

Palo alto, calif. & minneapolis, minn.--(business wire)--gero, a leading ai-driven biotechnology company focused on aging and longevity and foxo technologies inc. (nyseam: foxo), a leader in epigenetic biomarker discovery and commercialization, today announced the commencement of discussions to form a strategic collaboration between the two companies. as a result, foxo and gero will seek to develop an ai-driven personalized wellness and longevity recommendation engine based on proprietary epige.
FOXO Ratings Summary
FOXO Quant Ranking